Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Formulated PSTA vs PSTA Alone vs Suprachoroidal Triamcinolone in DME
NCT05464953Completed
- Sponsor
- Al-Azhar University
- Start
- Jan 2020
- Primary completion
- Apr 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Trial of triamcinolone in diabetic macular edema (DME) (3 arms), sponsored by Al-Azhar University. Primary endpoints: Best-Corrected Visual Acuity at 6 months and Central Macular Thickness at 6 months. Started Jan 2020; status: completed.
02
Drugs
triamcinolone
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT05464953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05464953.